Anti-depressants linked with blood clot condition: Study

Image
IANS London
Last Updated : Jul 25 2018 | 5:45 PM IST

Increased use of anti-depressants -- drugs used to treat major depressive disorders -- may be associated with developing a high risk of fatal blood clot condition, says a study.

The study showed that a relationship exists between depression, antidepressant use, and venous thromboembolism (VTE), in which a blood clot forms in the veins of the legs or lungs and is associated with high healthcare costs.

According to the study, led by Setor Kunutsor from the University of Bristol in Britain, each of the various classes of antidepressant medications are associated with an increased risk of VTE.

However, with conflicting reports on whether depression and use of anti-depressant drugs might be associated with an increased risk of VTE, for the study, published in Annals of Medicine, the team analysed eight observational studies with data on 960, 113 non-overlapping participants and 9,027 VTE cases were included.

The effect of antidepressant drugs on VTE may be a class effect and the mechanistic pathways underlying these associations deserve further evaluation, the results showed.

Anti-depressant medication have multiple indications which include anxiety, pain and neuralgia, and their use is on global scale.

The study highlights the need for prescribers and healthcare professionals to evaluate patients to determine their excess risk of VTE during management, the researchers noted.

--IANS

asj/vd

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 25 2018 | 5:38 PM IST

Next Story